Therapy for the treatment of myelofibrosis has received significant results from phase 3 trial [...]
Thu, Aug 18, 2022
The SMC approval brings much-needed boost to asthma sufferers across Scotland [...]
Thu, Aug 18, 2022
The company's clinical development programme is to be discontinued following a recent evaluation [...]
Wed, Aug 17, 2022
Funds will allow researchers to focus on improving the lives of children with rare conditions [...]
Wed, Aug 17, 2022

 

The Learning  Partnership